Cormorant Asset Management LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:05 pm Sale | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Cormorant Asset Management LP | 1,100,000 2.730% | -336,322 (-23.42%) | Filing |
| 2022-02-14 3:04 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Cormorant Asset Management LP | 1,436,322 6.280% | 1,436,322 (New Position) | Filing |